These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 829618

  • 1. [Clinical experiences with depot neuroleptics].
    Peterová E, Baudis P, Dvoráková M, Vencovský E.
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():173-6. PubMed ID: 829618
    [Abstract] [Full Text] [Related]

  • 2. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 3. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
    Lipska B, Szukalski B, Nurowska K, Welbel L.
    Psychiatr Pol; 1986 Apr 29; 20(1):1-7. PubMed ID: 3725983
    [No Abstract] [Full Text] [Related]

  • 4. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 5. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R, Wegener G.
    Nervenarzt; 1979 Aug 10; 50(8):534-9. PubMed ID: 394015
    [No Abstract] [Full Text] [Related]

  • 6. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Aug 10; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 7. Delusions of infestation: treatment by depot injections of neuroleptics.
    Frithz A.
    Clin Exp Dermatol; 1979 Dec 10; 4(4):485-8. PubMed ID: 535177
    [No Abstract] [Full Text] [Related]

  • 8. Depot neuroleptics in the treatment of acute psychoses.
    Guarneri M, Placidi GF, Cassano GB.
    Encephale; 1979 Dec 10; 5(2):189-93. PubMed ID: 477594
    [Abstract] [Full Text] [Related]

  • 9. Depot injections for affective disorders.
    Naylor GJ, Scott CR.
    Br J Psychiatry; 1980 Jan 10; 136():105. PubMed ID: 7357213
    [No Abstract] [Full Text] [Related]

  • 10. Depot antipsychotics. Patient characteristics and prescribing pattern.
    Al-Sughayir MA.
    Saudi Med J; 2000 Dec 10; 21(12):1178-81. PubMed ID: 11360095
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW, Sheffield BF.
    Br J Psychiatry; 1976 Nov 10; 129():476-81. PubMed ID: 990663
    [Abstract] [Full Text] [Related]

  • 12. [Long-term treatment with neuroleptics in schizophrenic and paraphrenic psychoses].
    König L.
    Z Arztl Fortbild (Jena); 1977 Apr 15; 71(8):410-4. PubMed ID: 878514
    [No Abstract] [Full Text] [Related]

  • 13. Depot neuroleptics in a community mental health service.
    Blake B.
    Br Med J; 1979 Jul 07; 2(6181):48-9. PubMed ID: 466266
    [No Abstract] [Full Text] [Related]

  • 14. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
    Wistedt B, Jørgensen A, Wiles D.
    Psychopharmacology (Berl); 1982 Jul 07; 78(4):301-4. PubMed ID: 6818587
    [Abstract] [Full Text] [Related]

  • 15. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM.
    J Clin Psychiatry; 1984 May 07; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [Abstract] [Full Text] [Related]

  • 16. Lowest effective dose of depot neuroleptics.
    Hoencamp E, Haffmans PJ, Jansen GS.
    Br J Psychiatry; 1992 Mar 07; 160():422-3. PubMed ID: 1348655
    [No Abstract] [Full Text] [Related]

  • 17. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May 07; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 18. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B.
    Acta Psychiatr Scand; 1981 Jul 07; 64(1):65-84. PubMed ID: 7032224
    [Abstract] [Full Text] [Related]

  • 19. Depot injections and tardive dyskinesia.
    Gibson AC.
    Br J Psychiatry; 1978 Oct 07; 133():361-5. PubMed ID: 709010
    [Abstract] [Full Text] [Related]

  • 20. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC, Sweet RA, Chengappa KN, Reddy RR, Jeste DV.
    Int J Geriatr Psychiatry; 2002 Nov 07; 17(11):1012-7. PubMed ID: 12404650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.